Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Gastric Cancer. 2017 Feb 1;20(5):772–783. doi: 10.1007/s10120-017-0692-y

Fig. 5.

Fig. 5

a–b TFF1 protein expression in gastric cancers. a Immunostaining showed moderate TFF1 immunopositivity in gastric mucosal epithelial cells (left panel) and gastric cancers (middle panel). Right panel depicts TFF1 immunonegativity found in gastric cancers. b Kaplan–Meier plots indicating overall survival rates for gastric cancer patients showing an absence of both GKN2 and TFF1 expression, gastric cancer patients showing either GKN2 or TFF1 expression, and gastric cancer patients showing co-expression of GKN2 and TFF1. The P value was determined using the log-rank test